July 1, 2025

A federal judge in Delaware has dismissed a lawsuit filed by Acuitas Therapeutics against Alnylam Pharmaceuticals. The complaint sought to add Acuitas scientists as inventors on seven patents held by Alnylam, which are related to mRNA technology—a cornerstone in the development of COVID-19 vaccines. The court ruled that Acuitas failed to demonstrate that its scientists…

In a recent development, Apple has leveled accusations against a former senior engineer, alleging that they misappropriated trade secrets related to Apple’s Vision Pro headset before transitioning to a new position at Snap Inc. The engineer is said to have taken these proprietary insights to Snap, where they are reportedly contributing to the company’s ongoing…

An Illinois federal judge recently ruled that a company may have a viable opportunity to challenge two of General Motors Co.’s design patents for fenders. This challenge follows the Federal Circuit’s implementation of more flexible standards in determining the obviousness of design patents. The company had previously succeeded in persuading the Federal Circuit to embrace…

In July, the Federal Circuit’s docket will feature some closely observed cases centered around intellectual property disputes. Among these is Apple’s effort to reverse a legal decision which led to the removal of the blood oxygen monitor feature from its Apple Watch. This move could have significant implications for the tech giant’s product capabilities and…

The recent term of the U.S. Supreme Court has produced dissents that delve beyond the surface of judicial reasoning, raising critical discussions about the institution’s future. Justices have been vocal, expressing concerns that their colleagues’ decisions might be encouraging executive overreach, undermining public trust in the judiciary, and putting democracy at risk. These critiques occasionally…

The full Federal Circuit has declined Mylan’s request to reconsider its March decision regarding the company’s generic version of the schizophrenia treatment, Invega Trinza. The earlier ruling determined that introducing this generic drug would lead physicians to infringe on an existing patent owned by Janssen. This judicial decision represents a significant point in the ongoing…

A California appeals court has upheld a decision in favor of Warner Bros. in a lawsuit brought by a writer who claimed the studio’s film, “Life of the Party,” was a “cinematic clone” of her original concept. The writer had alleged that her idea—which involved a storyline of a mother attending college with her daughter—had…

The U.S. Supreme Court’s recent decision to restrict federal judges from issuing nationwide injunctions is set to dominate the justices’ agenda over the coming months. This significant ruling curtailed the ability of lower courts to enact universal injunctions, a tool often employed to block presidential policy across the entire country. The decision not only addresses…